Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Shriqui, C. L.
	Articles by Jones, B. D.
	Search for Related Content



	PubMed Citation
	Articles by Shriqui, C. L.
	Articles by Jones, B. D.

Am J Psychiatry 1992; 149:391-393
Copyright © 1992 by American Psychiatric Association

BRIEF REPORTS

Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study

CL Shriqui, J Bradwejn, L Annable and BD Jones
Centre de recherche Universite Laval Robert-Giffard, Department of Psychiatry, Laval University, Beauport, Quebec, Canada.

The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.

This article has been cited by other articles:

D. Q Pham and R. Plakogiannis
Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2
Ann. Pharmacother., December 1, 2005; 39(12): 2065 - 2071.
[Abstract] [Full Text] [PDF]

E. Shamir, Y. Barak, I. Shalman, M. Laudon, N. Zisapel, R. Tarrasch, A. Elizur, and R. Weizman
Melatonin Treatment for Tardive Dyskinesia: A Double-blind, Placebo-Controlled, Crossover Study
Arch Gen Psychiatry, November 1, 2001; 58(11): 1049 - 1052.
[Abstract] [Full Text] [PDF]

Get information about faster international access.